Original source

Summary

Morrison & Foerster client alert mapping the legal architecture of the October 30 2025 Trump-Xi Busan trade pause. Cross-references White House Fact Sheet against MOFCOM Remarks. Headline mechanics: U.S. suspends BIS “Affiliates Rule” (50% ownership extension of Entity List / MEU List / sanctions) for one year through November 9 2026; China suspends most October 2025 rare earth controls and removes 15 U.S. entities from its Export Control List. Tariff: average U.S. rate on Chinese imports drops ~57% → ~47%; fentanyl tariff halved 20%→10%. Critical ambiguity: White House describes “de facto removal of controls” on rare earths/gallium/germanium/antimony/graphite for U.S. end users; MOFCOM remarks omit that language — the status of China’s April 2025 medium/heavy REE controls remains unresolved.

Key Points

  • Affiliates Rule (BIS, formerly published Sept 2025): extended Entity List / MEU List / § 744.8 sanctions licensing requirements to entities ≥50% owned by listed parties → suspended one year through Nov 9 2026 (BIS final rule formally posted)
  • China April 4 UEL Notice (No. 7 [2025]) Unreliable Entity List measures: suspended one year from Nov 10 2025
  • China March 4 UEL Notices (Nos. 5, 6 [2025]): terminated (not just suspended)
  • Export Control List: China removes 15 U.S. entities (March 4 Notice No. 13); suspends one year measures against 16 U.S. entities (April 4 Notice No. 21)
  • Article 2 of MOFCOM Announcement No. 46 [2024]: dual-use exports to U.S. of gallium / germanium / antimony / ultra-hard-materials with heightened end-user review → suspended Nov 9 2025 → Nov 27 2026
  • Tariff package: U.S. fentanyl-related tariff 20%→10%; Section 301 exclusions extended through Nov 10 2026; China terminates retaliatory tariffs on listed agricultural goods (chicken, wheat, corn, cotton, sorghum, soybeans, pork, beef, seafood, fruits, vegetables, dairy); China continues 24% suspension of broader retaliatory surcharge but retains 10% additional duty on all U.S.-origin imports
  • Critical legal ambiguity: White House Fact Sheet says “de facto removal of controls” on REE/gallium/germanium/antimony/graphite for U.S. end users; MOFCOM Remarks lack that language — the April 2025 medium-and-heavy REE controls (samarium, gadolinium, terbium, dysprosium, lutetium, scandium, yttrium) status is unresolved
  • AI-chip carve-out: Trump signaled most-advanced AI chips will continue to be U.S.-only — independent of trade pause
  • China’s UEL: >70 entities designated since 2023; usage frequency increased 2025
  • Both sides retain full legal infrastructure to re-impose restrictions quickly

Newsletter Angles

  • The asymmetric read-out as the actual story: White House and MOFCOM say overlapping but non-identical things. The rare-earth language gap is the load-bearing one. U.S. coverage has largely treated the deal as a clean rare-earth thaw because the White House Fact Sheet describes “de facto removal of controls” — but MOFCOM never said that, and the April 2025 medium/heavy REE licensing regime is precisely the regime that constrains Western defense manufacturing. The U.S. announced relief that China did not announce granting. Pair with FDD and East Asia Forum sources for the same conclusion from different lenses (think tank + academic + law firm).
  • The Affiliates Rule pause as the most consequential U.S. move: Mostly under-reported. The Affiliates Rule would have automatically subjected ≥50%-owned subsidiaries of Entity-Listed companies (Huawei, SMIC, etc.) to U.S. licensing requirements. Suspending it for a year is a significant compliance respite for U.S. and multinational firms — and a tactical concession from the U.S. side that wasn’t on the headline trade-deal scoreboard. Worth pairing with Anthropic’s Pentagon supply-chain risk designation (different lever, same architecture: list-based U.S. export-control regime as industrial-policy weapon).
  • Both sides are testing a stabilization period, not climbing down: MoFo’s careful framing — “Both governments appear to be testing a temporary stabilization period rather than considering a more permanent rollback of strategic controls” — is the analytical posture U.S. coverage rarely adopts. The wiki should treat the pause as an inflection in pace, not a directional change. The pause expires Nov 2026; the Trump administration’s domestic AI / semi-export policy continues to escalate independently (see Trump May Review AI Models Before Release — Forbes - 2026-05-04).

Entities Mentioned

  • China — counterparty
  • Donald Trump — bilateral principal
  • Xi Jinping — bilateral principal
  • BIS (U.S. Bureau of Industry and Security) — Commerce sub-agency; published Affiliates Rule
  • MOFCOM (China Ministry of Commerce) — issued multiple suspension notices
  • Anthropic — context (Pentagon supply-chain risk designation outside this deal)

Concepts Mentioned

Quotes

“the very fact that certain issues were negotiated in this manner at the head-of-state level is itself notable. In particular, the fact that the timeline for a published BIS rule — one not specific to China — would be revised bilaterally as part of trade discussions was widely seen as a change from past practice.” — MoFo

“Both governments appear to be testing a temporary stabilization period rather than considering a more permanent rollback of strategic controls.” — MoFo

“the most advanced [chips] … the United States will not let anybody have them other than the United States.” — Trump (cited from Reuters, Nov 3 2025)

Notes

Morrison & Foerster client alerts are tier-1 for U.S. export-control regulatory analysis (the firm’s national-security trade practice is among the most-cited). Treat as legal analysis, not journalism — language is studied; the framing of U.S./China asymmetric read-outs is precise and worth quoting. Backfill source ingested today (Nov 13 2025 publication) because the rare-earth news cluster (Nov-Dec 2025) was not previously processed; this and the East Asia Forum + FDD pieces together establish the legal-and-empirical baseline for any future rare-earths newsletter piece. The rare-earth licensing-regime ambiguity flagged here is load-bearing for any analysis of the post-Busan thaw: future ingests should resolve it before treating U.S. industrial supply chains as having received material relief.